Disclosed are compounds of formula A, E, and F, wherein the substituents are as defined in the specification. The compounds are liver X receptor (LXR) modulators useful in the treatment of dermal diseases, disorders or conditions. Examples of compounds of formula A, E, and F are: 1-(2-chlorophenyl)-5-(5-(3-(methylsulfonyl)phenyl)-1,3,4-oxadiazol-2-yl)-1H-pyrazole-3-carboxylic acid methylthiomethyI 2-(4-bromo-5-(3’-(methylsulfonyl)biphenyl-4-yl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)acetate chloromethyl 2-(5-(5-(3-(methylsulfonyl)phenyl)thiophen-2-yl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)acetate
